Cyclophosphamide pulses in the treatment of rheumatic diseases: an update
De Vita, S.; Neri, R.; Bombardieri, S.
Clinical and Experimental Rheumatology 9(2): 179-193
1991
ISSN/ISBN: 0392-856X PMID: 2060164 Document Number: 378772
Document emailed within 1 workday
Related Documents
Nordstrom, D. 1995: Intravenous cyclophosphamide pulses in the treatment of pyoderma gangrenosum associated with rheumatoid arthritis Journal of Rheumatology 22(5): 1000-1001De Vita, S.; Fossaluzza, V. 1992: Treatment of idiopathic inflammatory myopathies with cyclophosphamide pulses: clinical experience and a review of the literature Acta Neurologica Belgica 92(4): 215-227
Baraliakos, X.; Braun, J.; Conaghan, P.G.; Østergaard, M.; Pincus, T. 2018: Update on imaging in rheumatic diseases Clinical and Experimental Rheumatology 36 Suppl. 114(5): 2
Rhein, E.; Wenig, A. 1970: Clinical experiences in the treatment of rheumatic and non-rheumatic infectious diseases with an antiphlogistic agents Zeitschrift für Allgemeinmedizin 46(29): 1464-1466
Solomon, S.D. 1978: Update: treatment of rheumatic disease Journal of the Medical Society of New Jersey 75(12): 855-858
Neumann, W.; Barthel, E.; Tanner, E.; Seidel, K. 1970: Gm-properties in rheumatic diseases with reference to chronic progressive polyarthritis. I. Gm(a) and Gm(x) factors in rheumatic diseases Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 25(7): 308-311
Kato, K.; Watanabe, R.; Ito, E.; Sakamoto, T.; Morishima, M.; Hoshino, K.; Tanaka, M.; Tadokoro, N. 1986: Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases Nihon Sanka Fujinka Gakkai Zasshi 38(12): 2241-2250
Takatsu, T.; Kino, M.; Tsujimoto, G.; Kaku, K.; Sonotani, N.; Suwa, M.; Morita, H.; Hirota, Y.; Tsutsumi, J.; Kubo, S.; Kawamura, K. 1979: Recurrence of rheumatic fever and valvular diseases--etiology of rheumatic fever, rheumatic carditis and recurrent rheumatic fever Nihon Rinsho. Japanese Journal of Clinical Medicine 37(8): 3082-3102
Vlak, T.; Pivalica, D.; Aljinović, J. 2013: Principles of extra-articular rheumatic diseases treatment--therapeutic dilemmas and treatment algorithms Reumatizam 60(2): 84-89
Wagner, I.; Heide, L. 2003: Salicin and treatment of rheumatic diseases Journal of Rheumatology 30(5): 1125
Banoo, H.; Rahman, S.; Alam, A.; Azad, A.K.; Sayeed, A.; Awwal, A. 1987: Prevalence of rheumatic fever and rheumatic heart diseases in school children in Dhaka city Bangladesh Medical Research Council Bulletin 13(2): 92-100
Waytz, P. 1983: Cytotoxic drugs in the treatment of rheumatic diseases Minnesota Medicine 66(7): 429
Miehlke, R.K. 1993: The role of surgical treatment of rheumatic diseases Der Internist 34(9): 852-857
Böhni, H. 1975: Judgement and treatment of rheumatic diseases in the general practice Therapeutische Umschau. Revue Therapeutique 32(11): 713-722
Nosonov, E.L. 2011: Perspectives of the treatment of rheumatic diseases in the beginning of the XXi century Terapevticheskii Arkhiv 83(5): 5-9
Klassen, E.; Meyer, H. 1978: Experiences with alrheumun suppositories in the treatment of rheumatic diseases Die Medizinische Welt 29(44): 1734-1736
Olhagen, B. 1985: Non-steroidal anti-inflammatory drugs in the treatment of rheumatic diseases Nordisk Medicin 100(1): 11-13
Mok, C.C.; Lau, C.S.; Wong, R.W. 1998: Toxicities of dapsone in the treatment of cutaneous manifestations of rheumatic diseases Journal of Rheumatology 25(6): 1246-1247
Sliwka, P. 1971: Acute treatment of selected rheumatic diseases with oxyphenbutazone and prednisolone Die Medizinische Welt 46: 1853-1855
Menarini, C.; Ferri, S.; Pazzaglia Minghetti, B. 1973: Our experience in the treatment of rheumatic diseases with 2-(4-isobutylphenyl)-propionic acid Minerva Medica 64(47): 2503-2506